Latest news
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock - Business WireBusiness Wire · Wed, 05 Aug 2026 03:45:00 GMTTwist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock - Business WireBusiness Wire · Tue, 04 Aug 2026 20:01:00 GMTTwist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Business WireBusiness Wire · Tue, 04 Aug 2026 12:00:00 GMTTwist Bioscience Announces Fiscal 2026 Third Quarter Financial Results - Business WireBusiness Wire · Mon, 03 Aug 2026 11:15:00 GMT